| 11:15 |
PANEL: Pioneering HealthTech: Hurdles Faced by Early-Stage Innovators
Early-stage healthtech funding pain-points are clear, high-risk nature, lengthy development cycles alongside regulatory complexities.
Entrepreneurs must demonstrate market potential, tackle reimbursement uncertainties, and emphasize a compelling value proposition to secure vital investment for transformative innovations, this panel will explore strategies new and developing healthtechs need to employ to navigate upcoming hurdles.
- How do investors assess the risk associated with early-stage healthtech investments, and what specific criteria do they look for
- How investors can support healthtech companies through the lengthy development and regulatory approval processes.
- Strategies recommended for effectively demonstrating market potential, addressing reimbursement uncertainties, and crafting a compelling value proposition that resonates with potential investors?
Vanela Bushi, Co-Founder & Partner, H-Tree Capital
Leigh Brody, Investment Manager, Albion VC
Sara Secall, Board Member, Ability Pharmaceuticals
  
|
| 15:30 |
PANEL: Beyond the Finish Line: Overcoming Late-Stage HealthTech Investment Barriers
Late-stage healthtech companies face a number of evolving difficulties from their first series rounds. Overcoming these demands a strong team, effective investor communication, proven execution, and a clear growth strategy for successful funding and realizing their potential.
This panel will look at strategies and best practices to navigate these roadblocks, empowering late-stage healthtech companies to thrive.
- How do investors assess a late-stage healthtech company's readiness for market validation and scalability, and what criteria is considered to evaluate its potential for sustained growth
- What strategies have successful late-stage healthtech companies employed to navigate complex regulatory landscapes, secure reimbursement, and address financial challenges
- Examples of effective partnership and collaboration approaches that have proven beneficial companies seeking to expand their market presence and overcome competition
Jia-Yi Har, Partner, Cathay Capital
Samuel Levy, Founding Partner, Lauxera Capital
Assaf Barnea, Managing Partner, Sanara Ventures
  
|
